시장보고서
상품코드
2019943

유전자 발현 분석 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

Global Gene Expression Analysis Market Size, Share, Trends & Growth Analysis Report 2026-2034

발행일: | 리서치사: 구분자 Value Market Research | 페이지 정보: 영문 160 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    




가격
PDF & Excel (Single User License) help
PDF & Excel 보고서를 1명만 이용할 수 있는 라이선스입니다. 텍스트 발췌나 도표 복사는 Value Market Research를 인용하여야 하며, 사내용 문서에 한해 가능합니다. 인쇄는 가능하지만, 인쇄물은 구매한 조직 내에서만 보관해야 합니다. 또한, 보고서 내용을 AI 도구나 자동 분석 플랫폼에 업로드하거나, 외부 공개 및 상업적 이용은 금지되어 있습니다.
US $ 3,920 금액 안내 화살표 ₩ 5,790,000
PDF & Excel (10-user License) help
PDF & Excel 보고서를 동일 기업내 10명까지 이용할 수 있는 라이선스입니다. 텍스트 발췌나 도표 복사는 Value Market Research를 인용하여야 하며, 사내용 문서에 한해 가능합니다. 인쇄는 가능하지만, 인쇄물은 구매한 조직 내에서만 보관해야 합니다. 또한, 보고서 내용을 AI 도구나 자동 분석 플랫폼에 업로드하거나, 외부 공개 및 상업적 이용은 금지되어 있습니다.
US $ 4,730 금액 안내 화살표 ₩ 6,986,000
PDF & Excel (Corporate User License) help
PDF & Excel 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다.
US $ 7,430 금액 안내 화살표 ₩ 10,974,000
카드담기
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

유전자 발현 분석 시장 규모는 2025년 58억 2,000만 달러에서 2026년부터 2034년까지 CAGR 10.83%로 성장하여 2034년에는 146억 8,000만 달러에 달할 것으로 예측됩니다.

전 세계 유전자 발현 분석 시장은 유전체학의 발전과 맞춤의료 관련 연구개발의 증가로 인해 빠르게 성장하고 있습니다. 이 기술을 통해 과학자들은 유전자 활성을 연구하고 질병의 메커니즘을 이해할 수 있으며, 암 연구, 신약 개발, 진단 등의 분야에서 매우 중요한 역할을 하고 있습니다. 정밀 헬스케어에 대한 관심이 높아지면서 시장 수요가 크게 증가하고 있습니다.

주요 촉진요인으로는 생명공학 및 제약 연구에 대한 투자 증가와 만성질환의 유병률 증가를 꼽을 수 있습니다. 차세대 염기서열 분석(NGS), 마이크로어레이와 같은 첨단 기술의 도입으로 보다 정확하고 높은 처리량의 유전자 분석이 가능해졌습니다. 또한, 정부의 자금 지원과 연구 이니셔티브가 전 세계 유전체학 연구의 확장을 뒷받침하고 있습니다.

인공지능과 빅데이터 분석의 통합으로 유전자 발현 연구의 효율성과 정확성이 향상되고 있어 향후 전망은 여전히 밝습니다. 임상 진단 및 표적 치료에서 유전자 분석의 적용 확대는 시장 성장을 더욱 촉진할 것입니다. 헬스케어가 맞춤형 치료 접근 방식으로 계속 전환함에 따라 이 시장은 크게 확대될 것으로 예상됩니다.

목차

제1장 소개

제2장 주요 요약

제3장 시장 변수, 동향, 프레임워크

제4장 세계의 유전자 발현 분석 시장 : 최종사용자별

제5장 세계의 유전자 발현 분석 시장 : 제품별

제6장 세계의 유전자 발현 분석 시장 : 용도별

제7장 세계의 유전자 발현 분석 시장 : 서비스별

제8장 세계의 유전자 발현 분석 시장 : 지역별

제9장 경쟁 구도

제10장 기업 개요

KSM 26.05.08

The Gene Expression Analysis Market size is expected to reach USD 14.68 Billion in 2034 from USD 5.82 Billion (2025) growing at a CAGR of 10.83% during 2026-2034.

The global gene expression analysis market is witnessing rapid growth due to advancements in genomics and increasing research in personalized medicine. This technology allows scientists to study gene activity and understand disease mechanisms, making it crucial in areas such as cancer research, drug development, and diagnostics. The growing focus on precision healthcare is significantly boosting market demand.

Key drivers include rising investments in biotechnology and pharmaceutical research, along with increasing prevalence of chronic diseases. The adoption of advanced technologies such as next-generation sequencing (NGS) and microarrays is enabling more accurate and high-throughput gene analysis. Additionally, government funding and research initiatives are supporting the expansion of genomics-based studies worldwide.

Future prospects remain strong as the integration of artificial intelligence and big data analytics enhances the efficiency and accuracy of gene expression studies. The increasing application of gene analysis in clinical diagnostics and targeted therapies will further drive market growth. As healthcare continues to shift toward personalized treatment approaches, this market is expected to expand significantly.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By End-User

  • Pharmaceutical & Biotechnology Companies
  • Academic & Research Institutes
  • Contract Research Organizations
  • Others

By Product

  • Consumables
  • Instruments

By Application

  • Drug Discovery
  • Diagnosis
  • Research

By Service

  • Gene Expression Profiling Services
  • Sequencing Services
  • Bioinformatics Solutions
  • Others

COMPANIES PROFILED

  • General Electric Company, , Illumina, Thermo Fisher Scientific, BioRad Laboratories, F HoffmannLa Roche Ltd, Pacific Biosciences of California, BGI, PerkinElmer Inc, Agilent Technologies
  • We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY END-USER 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast End-user
  • 4.2. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY PRODUCT 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Product
  • 5.2. Consumables Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY APPLICATION 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Application
  • 6.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Diagnosis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Research Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY SERVICE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Service
  • 7.2. Gene Expression Profiling Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Sequencing Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.4. Bioinformatics Solutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL GENE EXPRESSION ANALYSIS MARKET: BY REGION 2022-2034 (USD MN)

  • 8.1. Regional Outlook
  • 8.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.2.1 By End-user
    • 8.2.2 By Product
    • 8.2.3 By Application
    • 8.2.4 By Service
    • 8.2.5 United States
    • 8.2.6 Canada
    • 8.2.7 Mexico
  • 8.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.3.1 By End-user
    • 8.3.2 By Product
    • 8.3.3 By Application
    • 8.3.4 By Service
    • 8.3.5 United Kingdom
    • 8.3.6 France
    • 8.3.7 Germany
    • 8.3.8 Italy
    • 8.3.9 Russia
    • 8.3.10 Rest Of Europe
  • 8.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.4.1 By End-user
    • 8.4.2 By Product
    • 8.4.3 By Application
    • 8.4.4 By Service
    • 8.4.5 India
    • 8.4.6 Japan
    • 8.4.7 South Korea
    • 8.4.8 Australia
    • 8.4.9 South East Asia
    • 8.4.10 Rest Of Asia Pacific
  • 8.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.5.1 By End-user
    • 8.5.2 By Product
    • 8.5.3 By Application
    • 8.5.4 By Service
    • 8.5.5 Brazil
    • 8.5.6 Argentina
    • 8.5.7 Peru
    • 8.5.8 Chile
    • 8.5.9 Rest of Latin America
  • 8.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 8.6.1 By End-user
    • 8.6.2 By Product
    • 8.6.3 By Application
    • 8.6.4 By Service
    • 8.6.5 Saudi Arabia
    • 8.6.6 UAE
    • 8.6.7 Israel
    • 8.6.8 South Africa
    • 8.6.9 Rest of the Middle East And Africa

Chapter 9. COMPETITIVE LANDSCAPE

  • 9.1. Recent Developments
  • 9.2. Company Categorization
  • 9.3. Supply Chain & Channel Partners (based on availability)
  • 9.4. Market Share & Positioning Analysis (based on availability)
  • 9.5. Vendor Landscape (based on availability)
  • 9.6. Strategy Mapping

Chapter 10. COMPANY PROFILES OF GLOBAL GENE EXPRESSION ANALYSIS INDUSTRY

  • 10.1. Top Companies Market Share Analysis
  • 10.2. Company Profiles
    • 10.2.1 Illumina
    • 10.2.2 Thermo Fisher Scientific
    • 10.2.3 Bio-Rad Laboratories
    • 10.2.4 F. Hoffmann-La Roche Ltd
    • 10.2.5 Pacific Biosciences Of California
    • 10.2.6 BGI
    • 10.2.7 PerkinElmer Inc
    • 10.2.8 Agilent Technologies
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제
문의
원하시는 정보를
찾아 드릴까요?
문의주시면 필요한 정보를
신속하게 찾아드릴게요.
02-2025-2992
kr-info@giikorea.co.kr
문의하기